NHLBI Catalyze Grant: Product Definition for Medical Devices, Disease Targets, and Assay Development
SynopsisVersion HistoryRelated DocumentsPackage The National Heart, Lung, and Blood Institute (NHLBI) is offering the Catalyze Product Definition grant to accelerate basic science discoveries into viable diagnostic and therapeutic candidates for heart, lung, blood, and sleep (HLBS) diseases. This phased R61/R33 initiative provides early-stage translational support. The R61 phase focuses on identifying and testing initial medical device prototypes, defining disease targets, and piloting research tools. The R33 phase supports continued prototype development, [...]